High-flow Nasal Oxygen Therapy in COVID-19 Critically Ill Patients with Acute Hypoxemic Respiratory Failure: A Prospective Observational Cohort Study

BACKGROUND: Coronavirus disease-2019 (COVID-19) is prone to acute hypoxemic respiratory failure (AHRF). Because tracheal intubation is associated with a higher risk of death in these patients, AHRF employs high-flow nasal oxygen therapy (HFNOT). The goal of this study was to assess the effect of HFN...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Mohd Saif, Prakash, Jay, Banerjee, Sudipto, Bhattacharya, Pradip K, Kumar, Raman, Nirala, Deepak K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160615/
https://www.ncbi.nlm.nih.gov/pubmed/35719441
http://dx.doi.org/10.5005/jp-journals-10071-24167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160615/
https://www.ncbi.nlm.nih.gov/pubmed/35719441
http://dx.doi.org/10.5005/jp-journals-10071-24167

Ejemplares similares